SOLACI-CACI 2021 | Day 3: Andreas Grüentzig Auditorium – Pediatric Sessions

✔️ Day 3, SOLACI-CACI 2021.
✔️ Andreas Gruentzig Auditorium.

👨‍🏫 Program:

  • 00:05 – Current Status of Hybrid Interventions in Congenital Heart Disease
  • 01:35:43 – Radiation Protection: Are We Doing Enough?
  • 02:59:48 – Oral presentation
  • 04:14:06 – Oral presentation
  • 05:44:16 – Fetal, Neonatal and Expanding Limits Interventions.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 06:20 - TCT@SOLACI-CACI 2021 Session - "The Future of PCI" 01:33:19 - PCR@SOLACI-CACI 2021 Session 👉...

SOLACI-CACI 2021 | Day 2: Main Arena Auditorium

✔️ Day 2, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:01 - TCT@SOLACI-CACI 2021 Session: "Structural Heart Interventions" 01:30:26 - CRT@SOLACI-CACI 2021 Session 02:51:13 - Oral...

SOLACI-CACI 2021 | Day 3: Main Arena Auditorium

✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:05 - CBS@SOLACI-CACI Session 01:43:26 - CCI@SOLACI-CACI Session 03:07:38 - Oral presentation – Structural III 04:32:21 -...

SOLACI-CACI 2021 | Day 4: Main Arena Auditorium

✔️ Day 4, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:09 - The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology 01:30:55 - Current and Immediate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...